The price of Sunrun Inc (NASDAQ:RUN) shares last traded on Wall Street fell -5.98% to $10.54.
RUN stock price is now -19.79% away from the 50-day moving average and -25.53% away from the 200-day moving average. The market capitalization of the company currently stands at $2.36B.
With the price target reduced from $23 to $11, Piper Sandler Downgraded its rating from Overweight to Neutral for Sunrun Inc (NASDAQ: RUN). On November 08, 2024, Exane BNP Paribas Downgraded its previous ‘Outperform’ rating to ‘Neutral’ on the stock keeping its target price maintained at $14, while ‘Guggenheim’ rates the stock as ‘Neutral’
In other news, STEELE JEANNA, Chief Legal & People Officer sold 2,235 shares of the company’s stock on Dec 06 ’24. The stock was sold for $23,112 at an average price of $10.34. Upon completion of the transaction, the Chief Legal & People Officer now directly owns 303,401 shares in the company, valued at $3.2 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 06 ’24, Chief Executive Officer Powell Mary sold 2,931 shares of the business’s stock. A total of $30,320 was realized by selling the stock at an average price of $10.34. This leaves the insider owning 564,671 shares of the company worth $5.95 million. A total of 2.85% of the company’s stock is owned by insiders.
During the past 12 months, Sunrun Inc has had a low of $9.23 and a high of $22.26. As of last week, the company has a debt-to-equity ratio of 2.38, a current ratio of 1.47, and a quick ratio of 1.15. The fifty day moving average price for RUN is $13.2912 and a two-hundred day moving average price translates $14.157525 for the stock.
The latest earnings results from Sunrun Inc (NASDAQ: RUN) was released for 2024-09-30. The net profit margin was -18.80% and return on equity was -7.03% for RUN. The company reported revenue of $537.17 million for the quarter, compared to $563.18 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -4.62 percent.